The global Bioreactor market was valued at USD 499.76million in 2016 and is projected to reach USD 2194.78millionby 2025, growing at a CAGR of 17.87% from 2017 to 2025.
Bioreactor is a vessel in which a chemical process is carried out which involves organisms or biochemically active substances derived from such organisms. The market is expected to grow with increasing R&D Activities and investments in Biotechnology and biopharmaceuticals.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Rising chronic diseases prevalence
1.2 Soaring biopharmaceutical investments
1.3 Growing demand for therapeutically effective vaccines
1.4 Favorable government initiatives
1.5 Increasing number of novel compounds entering the clinical trials
2. Market Restraints
2.1 Regulatory concerns regarding single use bioreactor
2.2 Limited storage capacity
2.3 Vulnerability to leaching
Market Segmentation:
1. By Cell:
1.1 Mammalian Cells
1.2 Bacterial Cells
1.3 Yeast Cells
1.4 Others
2. By Molecule:
2.1 Monoclonal Antibodies
2.2 Vaccines
2.3 Recombinant Proteins
2.4 Stem Cells
2.5 Gene Therapy
2.6 Others
3. By Technology:
3.1 Wave-Induced Motion SUB
3.2 Stirred SUB
3.3 Single Use Bubble Column
3.4 Other SUB
4. By End User:
4.1 R&D organizations
4.2 Biopharma
4.3 Manufacturers
4.4 CMOs
5. By Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Thermo Fisher Scientific
2. PBS Biotech
3. GE Healthcare
4. Merck Group
5. Cellexus Ltd
6. Pall Corporation
7. Sartorius Stedium Biotech Group
8. Applikon Biotechnology, Inc.
9. GEA Group Aktiengesellschaft
10. BioTron Inc.
11. Bbi Biotech
12. Bailun Bio
13. CerCell
14. Eppendorf
15. Solaris Biotech Solutions
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Bioreactormarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL BIOREACTORMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL BIOREACTORMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL BIOREACTOR MARKET, BY CELL:
5.1 Mammalian Cells
5.2 Bacterial Cells
5.3 Yeast Cells
5.4 Others
6 GLOBAL BIOREACTOR MARKET, BY MOLECULE:
6.1 Monoclonal Antibodies
6.2 Vaccines
6.3 Recombinant Proteins
6.4 Stem Cells
6.5 Gene Therapy
6.6 Others
7 GLOBAL BIOREACTOR MARKET, BY TECHNOLOGY:
7.1 Wave-Induced Motion SUB
7.2 Stirred SUB
7.3 Single Use Bubble Column
7.4 Other SUB
8 GLOBAL BIOREACTOR MARKET, BY END USER:
8.1 R&D organizations
8.2 Biopharma
8.3 Manufacturers
8.4 CMOs
9 GLOBAL BIOREACTORMARKET, BY GEOGRAPHY
9.1 Overview
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
10 GLOBAL BIOREACTORMARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies
11 COMPANY PROFILES
11.1 Thermo Fisher Scientific
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 PBS Biotech
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 GE Healthcare
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Merck Group
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 Cellexus Ltd
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 Pall Corporation
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 Sartorius Stedium Biotech Group
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 Applikon Biotechnology, Inc.
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 GEA Group Aktiengesellschaft
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Development
11.10 BioTron Inc.
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Development
11.11 Bbi Biotech
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Development
11.12 Bailun Bio
11.12.1 Overview
11.12.2 Financial Performance
11.12.3 Product Outlook
11.12.4 Key Development
11.13 CerCell
11.13.1 Overview
11.13.2 Financial Performance
11.13.3 Product Outlook
11.13.4 Key Development
11.14 Eppendorf
11.14.1 Overview
11.14.2 Financial Performance
11.14.3 Product Outlook
11.14.4 Key Development
11.15 Solaris Biotech Solutions
11.15.1 Overview
11.15.2 Financial Performance
11.15.3 Product Outlook
11.15.4 Key Development
12 Appendix
12.1 Related Reports
The Stainless Steel Suspension Cell Culture Bioreactor Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competi...
The Bioreactor Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers/p...
Executive Summary
Azoth Analytics has released a research report titled "Global Organ Perfusion System Market (2023 Edition)" which provides a complete analysis of the Global Organ Perfusion System industry in terms of market segmentation By Component (Oxygenators, Bioreactor Perfusion ...
Overview of the Global Custom Bioreactor Control Market:
The report discusses everything a marketer requires before investing in the global Custom Bioreactor Control Market during the forecast period 2023-2030. It p...
Overview of the Global Bioreactor Automation Solutions Market:
The report discusses everything a marketer requires before investing in the global Bioreactor Automation Solutions Market during the forecast period 202...
The global Bubble Column Bioreactor market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in ...
The global Micro Bioreactor System market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in t...
The global Perfusion Bioreactor market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this...
The global Microbial Bioreactor market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this...
The global Parallel Bioreactor Systems market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players ...